National Institutes of Health Grant Search

The following government grants in the FederalGrants.com database contain the term National Institutes of Health in the listing.

Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.

 

 

 

 
 
 Grant TitleCFDAFunding Number
NIH Director's Pioneer Award (DP1 - Clinical Trial Optional) 93.310 RFA-RM-18-007
Targeted In Vivo Delivery of Gene Therapeutics for HIV Cure (R01 Clinical Trial Not Allowed) 93.242, 93.855 RFA-AI-18-016
Harnessing Big Data to Halt HIV (R01 Clinical Trial Optional) 93.242, 93.393, 93.394, 93.395, 93.396, 93.399, 93.855 PAR-18-764
BRAIN Initiative: Targeted BRAIN Circuits Projects- TargetedBCP (R01 Clinical Trial Not Allowed) 93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.313, 93.853, 93.865, 93.866, 93.867 RFA-NS-18-030
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed) 93.853 PAR-18-762
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems and/or Pharmacodynamic Markers to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not 93.853 PAR-18-763
Limited Competition: Interaction of HIV Infection and Alcohol Abuse on Central Nervous System Morbidity (U01 Clinical Trial Not Allowed) 93.273 RFA-AA-18-011
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed) 93.853 PAR-18-761
Summer Institute for Research Education in Biostatistics (R25 - Clinical Trials Not Allowed) 93.233, 93.837, 93.838, 93.839 RFA-HL-19-019
In Vivo Synaptic Function in Alzheimers Disease and Related Dementias (R21 Clinical Trial Not Allowed) 93.866 PAR-18-760
Novel Nucleic Acid Sequencing Technology Development (R21 Clinical Trial Not Allowed) 93.172 RFA-HG-18-002
Novel Nucleic Acid Sequencing Technology Development (R43/R44 Clinical Trial Not Allowed) 93.172 RFA-HG-18-003
Novel Nucleic Acid Sequencing Technology Development (R01 Clinical Trial Not Allowed) 93.172 RFA-HG-18-001
Administrative Supplements to NIGMS Predoctoral Training Grants for the Development of Activities to Prepare Trainees for Careers in the Biomedical Research Workforce (Admin Supp Clinical Trial Not Allowed) 93.859 PA-18-757
Development of Curricular or Training Activities in Rigor and Transparency to Enhance Reproducibility (Admin Supp Clinical Trial Not Allowed) 93.859 PA-18-756
Development of Curricular or Training Activities in Laboratory Safety (Admin Supp Clinical Trial Not Allowed) 93.859 PA-18-758
Development of Curricular or Training Activities in Skills Development (Admin Supp Clinical Trial Not Allowed) 93.859 PA-18-759
NIMH Career Transition Award for Tenure-Track Intramural Investigators (K22 No Independent Clinical Trials) 93.242 PAR-18-755
Geriatrics and Clinical Gerontology Research to Address Health Disparities in the U.S. (Admin Supp Clinical Trial Not Allowed) 93.866 PA-18-751
Administrative Supplements to NCI Grant and Cooperative Agreement Awards to Support Collaborations with the Drug Resistance and Sensitivity Network (DRSN)(Admin Supp Clinical Trial Not Allowed) 93.394, 93.395 PAR-18-752
Novel Biomarkers for the Development of HIV Incidence Assays with Improved Specificity (R21 Clinical Trials Not Allowed) 93.855 PA-18-754
Next-Generation Biologics for Sustained HIV Remission (R01 Clinical Trial Not Allowed) 93.242, 93.855 RFA-AI-18-017
Novel Biomarkers for the Development of HIV Incidence Assays with Improved Specificity (R01 Clinical Trial Optional) 93.855 PA-18-753
Examining Diversity, Recruitment and Retention in Aging Research (R24 Clinical Trial Not Allowed) 93.866 PAR-18-749
Research Supplements to Promote Data Sharing in Cancer Epidemiology Studies (Admin Supp Clinical Trial Not Allowed) 93.393 PA-18-748
Addressing the Challenges of the Opioid Epidemic in Minority Health and Health Disparities Research in the U.S. (R01 Clinical Trial Optional) 93.273, 93.279, 93.307, 93.313, 93.865, 93.866 PAR-18-747
Addressing the Challenges of the Opioid Epidemic in Minority Health and Health Disparities Research in the U.S. (R21 Clinical Trial Optional) 93.273, 93.279, 93.307, 93.313, 93.865, 93.866 PAR-18-745
NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional) 93.279 PAR-18-746
Impact of Initial Influenza Exposure on Immunity in Infants (U01 Clinical Trial Not Allowed) 93.855 RFA-AI-18-010
Mechanistic Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed) 93.846 RFA-AR-19-006
Mechanistic Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed) 93.846 RFA-AR-19-007
Pilot and Feasibility Clinical Research Grants in Kidney Diseases (R21 Clinical Trial Optional) 93.847 PAR-18-744
Pilot and Feasibility Clinical Research Grants in Urologic Disorders (R21 Clinical Trial Optional) 93.847 PAR-18-743
Revision Applications to National Cancer Institute (NCI)-supported P01 Awards to Include Research on the NCIs Provocative Questions (P01 Clinical Trial Optional) 93.393, 93.394, 93.395, 93.396, 93.399 RFA-CA-18-023
Exploring Epigenomic or Non-Coding RNA Regulation in the Development, Maintenance, or Treatment of Chronic Pain (R61/R33 Clinical Trial Optional) 93.213, 93.279 PAR-18-742
Revision Applications to National Cancer Institute (NCI) Supported R01 Awards to Include Research on the NCIs Provocative Questions (R01 Clinical Trial Optional) 93.393, 93.394, 93.395, 93.396, 93.399 RFA-CA-18-021
Revision Applications to National Cancer Institute (NCI) supported U01 Awards to Include Research on the NCIs Provocative Questions (U01 Clinical Trial Optional) 93.393, 93.394, 93.395, 93.396, 93.399 RFA-CA-18-022
Limited Competition: Building Infrastructure Leading to Diversity (BUILD) Initiative Phase II (U54 Clinical Trial Not Allowed) 93.310 RFA-RM-18-006
Mechanisms Underlying the Contribution of Type 1 Diabetes Disease-associated Variants (R01 Clinical Trial Not Allowed) 93.847, 93.855 RFA-DK-18-005
Revision Applications to National Cancer Institute (NCI)-supported P50 Awards to Include Research on the NCIs Provocative Questions (P50 Clinical Trial Optional) 93.393, 93.394, 93.395, 93.396, 93.399 RFA-CA-18-024
Search Results 1-40 of 10269
Page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 [Next]

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2018 FederalGrants.com